Oak Hill Advisors reported achieving a sixfold return on its AI investment through the deployment of the Hebbia platform ...
A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.